The invention is directed to compounds and methods of synthesizing hydroxyethylamino amides and their use in treatment of aspartyl protease mediated diseases and conditions.

 
Web www.patentalert.com

< Azetidine glycine transporter inhibitors

> RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

> N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
~ 00574